the limbic ANZUP Best of ASCO GU 2025
Overview
Join ANZUP, the limbic and a multidisciplinary expert panel as they share highlights from the ASCO GU 2025 Symposium and discuss their impact on patient care in Australia. Attend this insightful event in Melbourne or Brisbane.
Melbourne - leonda by the yarra
Thursday 13th March 2025 7:00pm - 9:00pm aedt
Hosted by A/Prof Andrew Weickhardt
Associate Professor Andrew Weickhardt is a medical oncologist at the Olivia Newton-John Cancer and Wellness Centre in Melbourne. He has an interest in using immunotherapy and personalised treatments for patients with genitourinary cancer. He is actively involved in translational research investigating biomarkers of response and resistance to these treatments, and is involved in several phase 1 trials of new drugs in development, including the ANZUP trial PCR-MIB using pembrolizumab with radiation in early bladder cancer.
Panel members include A/Prof David Pook, Prof Shahneen Sandhu and Prof Shomik Sengupta
Brisbane - Victoria Park function centre
Tuesday 18th March 2025 7:00pm - 9:00pm aest
Hosted by A/Prof Aaron Hansen
Aaron Hansen is a medical oncologist consulting at Icon Cancer Centre Greenslopes.
In 2015, A/Prof Hansen was appointed as a staff medical oncologist at the PM and was the medical oncology lead for genitourinary cancers and co-chair of the head and neck disease site at the Canadian Clinical Trials Group. After a decade working in Canada, A/Prof Hansen returned to Brisbane, however he remains an active member of the US National Cancer Institute Recurrent Metastatic Head and Neck Cancer Taskforce.
Alongside his practice at Icon, A/Prof Hansen works as a medical oncologist at Greenslopes Private Hospital and Princess Alexandra Hospital. With a passion for providing education and mentorship to the next generation of medical oncologists and cancer researchers, he is also an associate professor at the University of Queensland’s School of Medicine.
Panel members include Dr Natasha Roberts, A/Prof David Pryor, Dr Niara Oliveira and Prof Ian Vela